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To the Editor: The World Health Organization rec-
ommends that persons who return from pilgrimages to 
the Middle East with acute severe respiratory infections 
be tested to determine the cause of infection; the aim is 
to identify infections with the Middle East respiratory syn-
drome coronavirus (MERS-CoV), which have been occur-
ring in Saudi Arabia since 2012. Each year, >2.5 million 
persons from >180 countries, including 240,000 pilgrims 
from Europe, participate in Hajj, the Muslim pilgrimage to 
Mecca, Saudi Arabia. The gathering of mass numbers of 
persons during the Hajj increases the risk for the spread 
of respiratory infections among participants, and this risk 
has raised global concern that travelers returning from this 
pilgrimage could contribute to the international spread of 
MERS-CoV. During the 2012 and 2013 Hajj and Umrah 
(a minor pilgrimage) pilgrimages, no MERS cases in pil-
grims were reported (1,2). However, in 2014, cases of 
MERS-CoV infection were confirmed in 2 returning pil-
grims in the Netherlands (3). The International Health 
Regulations Emergency Committee advised all countries to 
improve awareness about MERS-CoV among pilgrims and 
to conduct surveillance for MERS-CoV among pilgrims 
during and after Hajj (4).
According to data from the International Air Trans-
port Association, Austria received an estimated 68,000 air 
travelers from Saudi Arabia, Jordan, Qatar, and the United 
Arab Emirates during June–November 2012 (a period en-
compassing 1 month before Ramadan and 1 month after 
the Hajj) (5); of these travelers, 1,000 were pilgrims per-
forming the Hajj. Relatively constant travel volumes to 
Austria on commercial flights out of these countries during 
2010–July 2014 have been confirmed by an analysis of air 
traffic statistics for Austria (A. Herndler, M. Rudolf, pers. 
comm.). We report on the investigation of illness among 
Austrian residents just after their return home from the 
2014 Hajj pilgrimage, which ended in early October.
As of October 27, 2014, a total of 7 Hajj pilgrims from 
Austria had sought medical care in different Austrian hos-
pitals/medical centers just after returning from Saudi Ara-
bia. The patients had fever and/or respiratory symptoms. 
A summary of the patients’ characteristics is presented in 
the Table. Of the 7 patients, 4 had cough, 1 had dyspnea, 
and 4 had fever. Patients 1, 2, and 7 had an acute febrile ill-
ness and clinical and/or radiologic evidence of pulmonary 
parenchymal disease. Patient 1 had sought medical care in 
Saudi Arabia, and patient 2 had been hospitalized for 10 
days in Saudi Arabia.
For the diagnosis of viral infection, a serum sample and 
a sputum, throat swab, or bronchoalveolar lavage sample 
were collected and sent to the Department of Virology, Med-
ical University of Vienna, Austria, for analysis. All samples 
were tested for MERS-CoV by using reverse transcription 
PCR targeting regions upstream of the envelope gene (6). 
Respiratory and serum samples from all 7 patients were 
negative for MERS-CoV. The respiratory samples were also 
tested for influenza A and B viruses and for rhinoviruses, as 
previously described (7–9). Of the 7 patients, 3 were positive 
for influenza B virus, 2 for influenza A(H3N2) virus, and 
2 for rhinoviruses (Table). Subsequent phylogenetic analy-
sis showed that the influenza A(H3N2) strains belonged to 
the A/Hong Kong/146/2013-like viruses and the influenza B 
strains belonged to the B/Phuket/3073/2013-like viruses of 
the Yamagata lineage, both of which are  subtype H3N2 and 
B strains included in the 2014–15 seasonal influenza vaccine 
for the Northern Hemisphere.
Our results showed that MERS-CoV was not de-
tected in any of these patients, and our findings support 
those from reports investigating illness among 2013 Hajj 
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pilgrims (2). Our data indicate that all patients had a respi-
ratory virus infection, and 5 of the 7 patients were infected 
with influenza virus. Six of the patients had not received 
seasonal influenza vaccine before traveling; for the seventh 
patient, influenza vaccine uptake data were not available. In 
2014 in Austria, the incidence of influenza-like illnesses was 
below the epidemic threshold during weeks 40–43: no cases 
of influenza were reported by the National Influenza Surveil-
lance network, Austria (http://www.influenza.at). Therefore, 
it is likely that these 7 patients became infected while at the 
Hajj, as reported for patients during previous Hajj seasons 
(10), or while traveling through international airports.
Our preliminary data indicate that influenza virus in-
fection was the cause of severe respiratory illness in 5 of 7 
Austrian pilgrims returning from the 2014 Hajj. Because in-
fluenza is a serious and potentially life-threatening illness, 
seasonal influenza vaccination is recommended for Hajj 
pilgrims. Accurate and rapid testing for MERS-CoV and 
other respiratory viruses, including influenza, is essential for 
identifying persons who may be contagious and for timely 
and effective antiviral drug treatment and, thus, should be 
considered for pilgrims with severe respiratory illness.
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Table. Characteristics of pilgrims who returned from the Hajj with acute respiratory illness and detectable virus in respiratory 




y/sex Other condition(s) Signs/symptoms 
Date of return from 
Hajj, Oct 2014 
Date of sample 
collection, Oct 2014 
Detected respiratory 
virus 
1 50/M Diabetes Fever of 38°C, 
pneumonia, bronchitis 
22  23 Influenza B† 
2 49/M Hypothyroidism Fever of 39°C, 
pneumonia, bronchitis 
21 22 Influenza A(H3N2)‡ 
3 47/F None Fever, cough 19  21 Influenza B† 
4 57/M None Cough, bronchitis 19  21 Influenza B† 
5 66/M Hypertension, 
cardiomyopathy 
Cough, lung infiltrates  13  20 Rhinovirus 
6 54/M Diabetes, hypertension Cough, bronchitis 10  13 Rhinovirus 
7 52/F Diabetes, hypertension, 
bronchial asthma 
Fever of 40°C, dyspnea 12  16 Influenza A(H3N2)‡ 
*All patients were negative for Middle East respiratory syndrome coronavirus. 
†B/Phuket/3073/2013-like virus, Yamagata lineage. 
‡A/Hong Kong/146/2013-like virus. 
 
